MRD Detection Gets New Standard with Pathlight
SAGA Diagnostics has launched Pathlight, a groundbreaking multi-cancer blood test for ultra-sensitive detection of MRD.
Read MorePosted by Chris Wolski | May 29, 2025 | Breast |
SAGA Diagnostics has launched Pathlight, a groundbreaking multi-cancer blood test for ultra-sensitive detection of MRD.
Read MorePosted by Chris Wolski | May 29, 2025 | Mass Spectrometry Instruments |
Seer, Inc. has launched its advanced Proteograph Product Suite, featuring the Proteograph ONE Assay and SP200 Automation Instrument.
Read MorePosted by Chris Wolski | May 28, 2025 | Breast |
Hologic and Biotheranostics unveiled new data showing that the Breast Cancer Index (BCI) test improves treatment decision-making.
Read MorePosted by Chris Wolski | May 28, 2025 | Infectious Diseases |
Rachel Burgoon developed a risk scoring tool to help physicians more effectively identify and treat drug-resistant infections.
Read MorePosted by Chris Wolski | May 23, 2025 | Urine Analyzers |
Vibrant Wellness has launched the Hormone Zoomer, a urine test providing analysis of hormone metabolism, endocrine disruptors, etc.
Read More